Furthermore, our results indicate that elaiophylin could inhibit tumor angiogenesis by downregulating both the VEGFR2 signaling pathway in endothelial cells and the HIF-1α levels in tumor cells, thereby resulting in the reduction of tumor growth (Figure 7). This evidence concerns the gene KDR and neoplasm.